Concepedia

Shilpa Kuttikrishnan

SK

19

Publications

652

Citations

13

H-Index

2016

Active since

Affiliations

Hamad Medical Corporation(Current)

Qatar University

National Center for Cancer Care and Research

Weill Cornell Medical College in Qatar

Cornell University

Shilpa Kuttikrishnan is an author at Hamad Medical Corporation specializing in medicine, cell biology, and cell death.

Top concepts

Publications per year

2016–2024

19

Publications

19

H2AX: A key player in DNA damage response and a promising target for cancer therapy

Kirti S. Prabhu, Shilpa Kuttikrishnan, Nuha Ahmad et al. · Biomedicine & Pharmacotherapy · 2024 · 116 citations · Full text

, , +24

Curcumin Induces Apoptotic Cell Death via Inhibition of PI3-Kinase/AKT Pathway in B-Precursor Acute Lymphoblastic Leukemia

Shilpa Kuttikrishnan, Kodappully Sivaraman Siveen, Kirti S. Prabhu et al. · Frontiers in Oncology · 2019 · 88 citations · Full text

, , +19

Sanguinarine mediated apoptosis in Non-Small Cell Lung Cancer via generation of reactive oxygen species and suppression of JAK/STAT pathway

Kirti S. Prabhu, Ajaz A. Bhat, Kodappully Sivaraman Siveen et al. · Biomedicine & Pharmacotherapy · 2021 · 55 citations · Full text

Curcumin-Mediated Degradation of S-Phase Kinase Protein 2 Induces Cytotoxic Effects in Human Papillomavirus-Positive and Negative Squamous Carcinoma Cells

Abdul Quaiyoom Khan, Kodappully Sivaraman Siveen, Kirti S. Prabhu et al. · Frontiers in Oncology · 2018 · 43 citations · Full text

Sanguinarine Induces Apoptosis Pathway in Multiple Myeloma Cell Lines via Inhibition of the JaK2/STAT3 Signaling

Sabah Akhtar, Iman W. Achkar, Kodappully Sivaraman Siveen et al. · Frontiers in Oncology · 2019 · 41 citations · Full text

Rows per page

1–5 of 19